Delve AI

San Francisco, CA, US

AI-native compliance automation platform using intelligent AI agents, serving over 500 companies across various compliance frameworks including SOC 2, HIPAA, ISO 27001, GDPR, and PCI-DSS.

Shareable draft

Check out Delve AI on @MedStartr Today AI-native compliance automation platform using intelligent AI agents, serving over 500 companies across various compliance frameworks including SOC 2, HIPAA, ISO 27001, GDPR, and PCI-DSS. #HealthcareInfrastructure #MedMo #MedStartrVentures

https://www.medstartr.ai/s/gSVG1mjmFGI

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in Delve AI

1 engagement

Problem Statement

Eliminate hours of manual compliance busywork for fast-growing companies.

Core Technology

AI-native compliance automation platform using intelligent AI agents

Key Differentiators

Uses intelligent AI agents to automate manual compliance work; Integrates with tools like GitHub, AWS, Slack, and custom applications; Evidence collection automation (auto-captures screenshots and logs); Infrastructure and code scanning with automatic misconfig patching; Security questionnaire autofill

Company Info

Business Model: B2B SaaS
Founded: 2023
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.delve.ai/compliance

Technologies

AI AgentsCompliance Automation

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Delve AI?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.